1. Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49.
- Author
-
Leichner PK, Akabani G, Colcher D, Harrison KA, Hawkins WG, Eckblade M, Baranowska-Kortylewicz J, Augustine SC, Wisecarver J, and Tempero MA
- Subjects
- Absorption, Aged, Antigens, Neoplasm immunology, Female, Gastrointestinal Neoplasms secondary, Glycoproteins immunology, Half-Life, Humans, Liver radiation effects, Male, Middle Aged, Radiotherapy Dosage, Spleen radiation effects, Tomography, Emission-Computed, Single-Photon, Yttrium Radioisotopes pharmacokinetics, Antibodies, Monoclonal, Gastrointestinal Neoplasms diagnostic imaging, Gastrointestinal Neoplasms radiotherapy, Indium Radioisotopes pharmacokinetics, Radioimmunotherapy, Yttrium Radioisotopes therapeutic use
- Abstract
Unlabelled: The objective of this work was to develop patient-specific dosimetry for patients with metastatic gastrointestinal tract cancers who received 111In-CC49 IgG for imaging before therapy with 90Y-CC49 IgG., Methods: Whole-body imaging of 12 patients, who received 111-185 MBq (3-5 mCi) of 111In-CC49, commenced in < 2 hr postinfusion and was continued daily for 4-5 days. SPECT data were acquired at 24 and 72 hr to determine the range of 111In-CC49 activity concentrations in tumors and normal organs. Time-activity curves were generated from the image data and scaled from 111In-CC49 to 90Y-CC49 for dosimetric purposes. Absorbed-dose calculations for 90Y-CC49 included the mean and range in tumor and normal organs. Computed 90Y-CC49 activity concentrations were compared with measurements on 10 needle biopsies of normal liver and four tumor biopsies., Results: In 9 of 10 normal liver samples, the range of computed 90Y-CC49 activity concentrations bracketed measured values. This was also the case for 3 of 4 tumor biopsies. Absorbed-dose calculations for 90Y-CC49 were based on patients' images and activities in tissue samples and, hence, were patient-specific., Conclusion: For the radiolabeled antibody preparations used in this study, quantitative imaging of 111In-CC49 provided the data required for 90Y-CC49 dosimetry. The range of activities in patients' SPECT images was determined for a meaningful comparison of measured and computed values. Knowledge of activity distributions in tumors and normal organs was essential for computing mean values and ranges of absorbed dose and provided a more complete description of the absorbed dose from 90Y-CC49 than was possible with planar methods.
- Published
- 1997